Table III.

Additional sensitivity analyses

Case	Total no.	Had AD (control group)	Had AD (emollient group)	RR (95% CI)	P value
Complete (no imputation)	108	23/53 (43.4%)	12/55 (21.8%)	0.50 (0.28-0.90)	.017
Missing (assumed to develop AD)	124	30/60 (50.0%)	21/64 (32.8%)	0.66 (0.43-1.01)	.03
Missing (assumed not to develop AD)	124	23/60 (38.3%)	12/64 (18.8%)	0.49 (0.27-0.89)	.02
Worst-case scenario∗	124	23/60 (38.3%)	21/64 (32.8%)	1.0 (0.61-1.62)	.99
Best-case scenario†	124	30/60 (50.0%)	12/64 (18.8%)	0.38 (0.2-0.66)	<.001

AD, Atopic dermatitis; RR, relative risk.

^∗Missing in emollient group assumed to have AD and in control group assumed not to have AD.

^†Missing in emollient group assumed not to have AD and in control group assumed to have AD.